Jonathan Graham

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Respiratory Syncytial Virus

Top Venues

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy (2024)